Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,244,000 | 1,456,000 | 1,681,000 | 1,645,000 | 1,642,000 |
| Marketable Securities | 285,000 | 338,000 | 504,000 | 533,000 | 781,000 |
| Receivables | 3,190,000 | 2,973,000 | 2,651,000 | 2,356,000 | 2,043,000 |
| Inventories | 1,873,000 | 1,799,000 | 1,669,000 | 1,451,000 | 1,397,000 |
| Other current assets | 1,190,000 | 1,170,000 | 1,023,000 | 1,033,000 | 847,000 |
| TOTAL | $8,782,000 | $7,736,000 | $7,528,000 | $7,018,000 | $6,710,000 |
| Non-Current Assets | |||||
| PPE Net | 4,429,000 | 4,156,000 | 3,964,000 | 3,760,000 | 3,666,000 |
| Other Non-Current Assets | 3,061,000 | 3,085,000 | 3,193,000 | 3,151,000 | 2,534,000 |
| TOTAL | $7,490,000 | $7,241,000 | $7,157,000 | $6,911,000 | $6,200,000 |
| Total Assets | $16,272,000 | $14,977,000 | $14,685,000 | $13,929,000 | $12,910,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,380,000 | 1,017,000 | 1,064,000 | 848,000 | 693,000 |
| Accrued Expenses | 2,302,000 | 1,939,000 | 1,962,000 | 1,939,000 | 2,116,000 |
| Other current liabilities | 877,000 | 865,000 | 800,000 | 700,000 | 0 |
| TOTAL | $5,791,000 | $5,032,000 | $5,050,000 | $4,806,000 | $4,274,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,364,000 | 1,279,000 | 966,000 | 635,000 | 644,000 |
| aiOther Non-Current Liabilities | 1,541,000 | 1,447,000 | 2,099,000 | 2,666,000 | 2,288,000 |
| TOTAL | $2,905,000 | $2,726,000 | $3,065,000 | $3,301,000 | $2,932,000 |
| Total Liabilities | $8,696,000 | $7,758,000 | $8,115,000 | $8,107,000 | $7,206,000 |
| Shareholders' Equity | |||||
| Common Shares | 219,000 | 108,000 | 108,000 | 54,000 | 54,000 |
| Retained earnings | 12,540,000 | 10,950,000 | 9,260,000 | 7,917,000 | 7,600,000 |
| Other shareholders' equity | -622,000 | -533,000 | -361,000 | -327,000 | -301,000 |
| TOTAL | $7,576,000 | $7,219,000 | $6,570,000 | $5,822,000 | $5,704,000 |
| Total Liabilities And Equity | $16,272,000 | $14,977,000 | $14,685,000 | $13,929,000 | $12,910,000 |